RAPT Therapeutics, Inc. ã¯èšåºæ®µéã®å
ç«åŠã«åºã¥ããã€ãªå»è¬åäŒæ¥ã§ãè
«çåŠããã³ççæ§çŸæ£ã®æºããããŠããªãããŒãºãæã€æ£è
ã®ããã®çµå£å°ååçæ³ã®çºèŠãéçºãããã³åååã«éç¹ã眮ããŠããŸããå瀟ã®äž»åè
«çè¬åè£ã¯ FLX475 ã§ããããã¯ãé²è¡çæ£è
ã察象ã«åå€çæ³ããã³ãã³ãããªãºãããšã®äœµçšçæ³ãšããŠèª¿æ»ãã第 1/2 çžèšåºè©Šéšãè¡ãããŠããçµå£å°åå CC ã¢ããŒã ã±ã¢ã«ã€ã³åå®¹äœ 4 æ®æè¬ã§ããå瀟ã®äž»åççè¬åè£ã¯ RPT193 ã§ãçççµç¹ãžã® 2 å T ãã«ããŒçްèã®ç§»åãéžæçã«é»å®³ããŸããå瀟ã¯ãŸããéçºã®çºèŠæ®µéã«ããäžè¬å¶åŸ¡éè±æå¶æ§ 2 ããã³é è¡åé§çްèãããŒãŒ 1 ãå«ãäžé£ã®ã¿ãŒã²ããã远æ±ããŠããŸããå瀟ã¯ä»¥åã¯FLX Bio, Inc.ãšããŠç¥ãããŠããŸãããã2019幎5æã«RAPT Therapeutics, Inc.ã«ç€Ÿåã倿ŽããŸãããRAPT Therapeutics, Inc.ã¯2015幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµãŠã¹ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã